Last reviewed · How we verify
Ganoderma
At a glance
| Generic name | Ganoderma |
|---|---|
| Also known as | Lingzhi |
| Sponsor | Xuanwu Hospital, Beijing |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV. (NA)
- Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial (NA)
- PsP Ganoderma Lucidum Supplementation and Biomarker Changes in Smokers (NA)
- Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors (PHASE2)
- The Effects on Sleep Quality of 1:4 Reishi Liquid Extract (NA)
- Physiological Effects of Nutritional Support in Patients With Parkinson's Disease (NA)
- Effects of a Mushroom Blend on Gastrointestinal Symptoms and the Microbiome (NA)
- Clinical Trial: Rapid Immune Modulating Effects (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ganoderma CI brief — competitive landscape report
- Ganoderma updates RSS · CI watch RSS
- Xuanwu Hospital, Beijing portfolio CI